{"symbol":"PFE","fiscalQuarter":"Q2-2017","reportDate":"2017-08-01","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q2-2017","postBrief":{"headline":"Pfizer Beats on EPS, Stock Down 0.24%","keyNumbers":[{"metric":"EPS","actual":"$0.67","expected":"N/A","surprise":"+1.52%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","We continue to focus on our core business areas."],"summary":"Management expressed satisfaction with the EPS results, highlighting their commitment to core business operations. However, they did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a slight beat on EPS, which indicates some operational success. However, the stock reacted negatively, declining by 0.24%. This could suggest that investors were looking for more comprehensive guidance or stronger revenue figures, which were not disclosed in this report.","metaDescription":"Pfizer Inc (PFE) Q2 2017 earnings: EPS beat by 1.52%. Stock down 0.24%. Full breakdown."}}